# Resolution Therapeutics: Biopharma, London, United Kingdom

> Resolution Therapeutics: Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.

Source: https://millionrounds.com/startup/resolution-therapeutics (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Biopharma startup](https://millionrounds.com/companies)

# Resolution Therapeutics

Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.

Email

Funding reported Last round: Series A

Biopharma London, United Kingdom

Follow Resolution Therapeutics and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Fresolution-therapeutics)

Company summary

- **Founded:** 2017 9 years old
- **Team:** 51 51 to 200 people
- **Funding reported:** 38M as listed, currency not stated
- **Last round:** Series A Apr 2022

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Resolution Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## What company datasets say Resolution Therapeutics raised

Funding, as reported

Reported in all **38M** in the source's currency

Rounds **3**

Last round **Series A**

Last round date **Apr 2022**

Investors listed **2**

## Founders and team

From Resolution Therapeutics's own website: 14 on the team.

- **Amir Hefni** CEO
- **Amol Ketkar** Chief Manufacturing and Technical Operations Officer
- **Daniel Kennedy** Chief Business Officer
- **Lucy Singah** Chief Financial Officer
- **Eli Gilsohn** VP, Intellectual Property & Technology Strategy
- **Louise Rowe** VP, Operations
- **Shazia Pandor** VP, People & Culture
- **Alessio D'addabbo** Analyst - Syncona
- **Bill Symonds** Non-Executive Director
- **Edward Hodgkin** Managing Partner - Syncona
- **Gonzalo Garcia** Principal - Syncona
- **Paul Sekhri** Chair
- **Prof. John Campbell** Director - TCAT Scottish National Blood Transfusion Service
- **Prof. Jonathan Fallowfield** Chair of Translational Liver Research

## Biopharma in United Kingdom

Startups like it

- [**Mereo Biopharma** London · founded 2015](https://millionrounds.com/startup/mereo-biopharma)
- [**Autolus** London](https://millionrounds.com/startup/autolus)
- [**Aiolos Bio** London · founded 2023](https://millionrounds.com/startup/aiolos-bio)
- [**Asklepios BioPharmaceutical** Easter Bush · founded 2001](https://millionrounds.com/startup/asklepios-biopharmaceutical)
- [**Genomics** Oxford · founded 2014](https://millionrounds.com/startup/genomics-2)
- [**Touchlight Genetics** founded 2007](https://millionrounds.com/startup/touchlight-genetics)
- [**Canton Strategic Holdings** Chester](https://millionrounds.com/startup/canton-strategic-holdings)
- [**PredictImmune** Cambridge · founded 2017](https://millionrounds.com/startup/predictimmune)

## Is this your company?

Add your raise, your deck and your story, and put Resolution Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)
